180 related articles for article (PubMed ID: 26232108)
1. Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-reactive protein.
Nijaguna MB; Schröder C; Patil V; Shwetha SD; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Hoheisel JD; Somasundaram K
J Proteomics; 2015 Oct; 128():251-61. PubMed ID: 26232108
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
3. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
4. An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.
Nijaguna MB; Patil V; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Somasundaram K
PLoS One; 2015; 10(9):e0137524. PubMed ID: 26390214
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
6. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway.
Couto M; Coelho-Santos V; Santos L; Fontes-Ribeiro C; Silva AP; Gomes CMF
J Cell Physiol; 2019 Nov; 234(11):19750-19760. PubMed ID: 30937892
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth.
Kumar DM; Thota B; Shinde SV; Prasanna KV; Hegde AS; Arivazhagan A; Chandramouli BA; Santosh V; Somasundaram K
J Proteome Res; 2010 Nov; 9(11):5557-67. PubMed ID: 20822092
[TBL] [Abstract][Full Text] [Related]
8. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
9. What is the role of CRP in glioblastoma?
Förnvik K; Maddahi A; Liljedahl E; Osther K; Salford LG; Redebrandt HN
Cancer Treat Res Commun; 2021; 26():100293. PubMed ID: 33385735
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
[TBL] [Abstract][Full Text] [Related]
11. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
12. Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma.
Arora A; Patil V; Kundu P; Kondaiah P; Hegde AS; Arivazhagan A; Santosh V; Pal D; Somasundaram K
Sci Rep; 2019 Feb; 9(1):2749. PubMed ID: 30808902
[TBL] [Abstract][Full Text] [Related]
13. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C pathway is involved in transcriptional regulation of C-reactive protein synthesis in human hepatocytes.
Ivashchenko Y; Kramer F; Schäfer S; Bucher A; Veit K; Hombach V; Busch A; Ritzeler O; Dedio J; Torzewski J
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):186-92. PubMed ID: 15539624
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
17. Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers (IL1β, IL6, TNFα, and CRP).
Alper B; Erdogan B; Erdogan MÖ; Bozan K; Can M
Mediators Inflamm; 2016; 2016():9894716. PubMed ID: 27127347
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop.
Kramer F; Torzewski J; Kamenz J; Veit K; Hombach V; Dedio J; Ivashchenko Y
Mol Immunol; 2008 May; 45(9):2678-89. PubMed ID: 18262272
[TBL] [Abstract][Full Text] [Related]
19. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.
Miyauchi E; Furuta T; Ohtsuki S; Tachikawa M; Uchida Y; Sabit H; Obuchi W; Baba T; Watanabe M; Terasaki T; Nakada M
PLoS One; 2018; 13(3):e0193799. PubMed ID: 29513714
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
